ASND
Ascendis Pharma A
$261.23
+$0.42 (+0.16%)Sep 10, 2026
Key metrics
The numbers that frame ASND today
- Market cap
- $17.16B
- P/E (TTM)
- 20.1
- EV / FCF
- 43.3
- Gross margin
- 91.3%
- EV / Sales
- 13.9
- ROIC
- 30.3%
- Div yield
- 0%
- Debt / equity
- 0.3
- 52wk Low
- $186.05
- 52wk High
- $282.15
Growth
Revenue and earnings trend for ASND
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about ASND
Is Ascendis Pharma A a good buy?
Yes. Ascendis Pharma A has mixed quality and strong momentum. Taken together, the setup leans positive. Growth looks excellent, which supports the long-term business case. We think Ascendis Pharma A is selling at a fair price.
What is the market capitalization of ASND?
Ascendis Pharma A's market capitalization is $17.16B.
What is the P/E ratio for ASND stock?
Ascendis Pharma A's current P/E ratio is 20.1.
What is the 52-week high for ASND stock?
The 52-week high for Ascendis Pharma A is $282.15. The current close of $261.23 is 7.4% below that high.
What is the 52-week low for ASND stock?
The 52-week low for Ascendis Pharma A is $186.05. The current close of $261.23 is 40.4% above that low.
Does ASND stock pay dividends?
Ascendis Pharma A does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for ASND?
Ascendis Pharma A's Debt / Equity ratio is 0.31.